Skip to content
★ Sign in to follow
BI

Biomoda Inc/NM Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by White Lewis, was filed 25 Feb 2010.

Biomoda Inc/NM: what insiders have been doing

Biomoda Inc/NM is a listed company. Its directors and officers file their transactions with SEC (Form 4). Biomoda Inc/NM has had no insider filing for more than a year; the last one goes back to 25 February 2010.

The full history, which starts in 2009, counts 5 purchases against no sales.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
8
Thresholds
n/a
Buy Volume
€14M
5 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 25 February 2010
Declarations8 total
  • ▲
    DirectorExecutives
    40,000 USD0SEC
    800,000 shares@ US$0.05Common StockSEC:0001185185-10-000209:0
    Canonical exit: 2 May 2010 (T+90)
  • ◆
    PresidentExecutives
    6B USD0SEC
    1,000,000 shares@ US$6,000.00Common StockSEC:0001185185-09-000209:0
  • ◆
    PresidentExecutives
    3B USD0SEC
    1,000,000 shares@ US$2,500.00Common StockSEC:0001185185-09-000209:1
  • ▲
    PresidentExecutives
    6M USD0SEC
    10,000 shares@ US$600.00Common StockSEC:0001185185-09-000209:2
    Canonical exit: 19 Nov 2008 (T+90)
  • ▲
    PresidentExecutives
    2M USD0SEC
    5,000 shares@ US$300.00Common StockSEC:0001185185-09-000209:3
    Canonical exit: 20 Nov 2008 (T+90)
  • ◆
    PresidentExecutives
    1M USD0SEC
    25,000 shares@ US$50.00Common StockSEC:0001185185-09-000209:4
  • ▲
    PresidentExecutives
    9M USD0SEC
    15,000 shares@ US$600.00Common StockSEC:0001185185-09-000209:5
    Canonical exit: 11 Dec 2008 (T+90)
  • ▲
    PresidentExecutives
    4M USD0SEC
    10,000 shares@ US$400.00Common StockSEC:0001185185-09-000209:6
    Canonical exit: 17 Dec 2008 (T+90)

8 of 8 declarations

About Biomoda Inc/NM

Biomoda Inc/NM is a NASDAQ-listed company focused on developing innovative solutions for disease detection. It aims to enhance medical diagnostics through advanced technologies.